Equus Total Return (EQS) 1.78 $EQS Equus Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Equus Total Return (EQS) 1.78 $EQS

Equus Announces Results of Annual Shareholder Meeting
Marketwire Canada - Thu Jun 16, 6:48AM CDT
HOUSTON, TX--(Marketwired - Jun 16, 2016) -  Equus Total Return, Inc. (NYSE: EQS) ("Equus" or the "Fund" announced the results of the Fund's Annual Meeting of Stockholders which took place on Monday, June 13, 2016. The purpose of the meeting was to consider and approve the following four proposals:
EQS: 1.78 (-0.01)

Equus Announces First Quarter Net Asset Value
Marketwire Canada - Thu May 12, 7:01AM CDT
HOUSTON, TX--(Marketwired - May 12, 2016) - Equus Total Return, Inc. (NYSE: EQS) (the "Fund" or "Equus" reports net assets as of March 31, 2016, of $37.6 million, an increase of approximately $0.3 million since December 31, 2015. Net assets per share increased to $2.96 as of March 31, 2016 from $2.94 as of December 31, 2015. Comparative data is summarized below (in thousands, except per share amounts):
EQS: 1.78 (-0.01)

Equus Announces Departure of Director
Marketwire Canada - Mon May 09, 12:23PM CDT
HOUSTON, TX--(Marketwired - May 9, 2016) - Equus Total Return, Inc. (NYSE: EQS) (the "Fund" or "Equus" announced the resignation of Alessandro Benedetti from the Fund's Board of Directors. Mr. Benedetti had been a member of the Equus Board since 2010, and was, at the time of his resignation, serving as a member of the Fund's committee of independent directors. Mr. Benedetti had also served as the Fund's Executive Chairman from June 2011 to June 2013.
EQS: 1.78 (-0.01)

Equus Announces 2015 Year-End Net Asset Value
Marketwired - Thu Mar 31, 5:24PM CDT
Equus Total Return, Inc. (NYSE: EQS) (the "Fund" or "Equus" reports net assets as of December 31, 2015, of $37.3 million, a decrease of approximately $0.3 million since September 30, 2015. Net assets per share decreased to $2.94 as of December 31, 2015 from $2.97 as of September 30, 2015. Comparative data is summarized below (in thousands, except per share amounts):
EQS: 1.78 (-0.01)

Equus Announces Departure of Longtime Director
Marketwired - Tue Jan 12, 11:20AM CST
Equus Total Return, Inc. (NYSE: EQS) (the "Fund" or "Equus" announced the resignation of Gregory J. Flanagan from the Fund's Board of Directors. Mr. Flanagan had been a member of the Equus Board since 1992, and was, at the time of his resignation, serving as a member of the Fund's committee of independent directors and as a member of its Audit Committee. Mr. Flanagan had served on various committees of the Equus Board during his tenure, and had also served as Chairman of the Board from May 2008 to February 2010, as well as CEO and President of the Fund from July 2009 to February 2010.
EQS: 1.78 (-0.01)

Equus Announces Third Quarter Net Asset Value
Marketwired - Thu Nov 12, 2:56PM CST
Equus Total Return, Inc. (NYSE: EQS) (the "Fund" or "Equus" reports net assets as of September 30, 2015, of $37.7 million, a decrease of approximately $0.3 million since June 30, 2015. Net assets per share decreased to $2.97 as of September 30, 2015 from $3.00 as of June 30, 2015. Comparative data is summarized below (in thousands, except per share amounts):
EQS: 1.78 (-0.01)

Equus Dispositions Yield $3.6 Million in Cash and a $0.9 Million Note
Marketwired - Mon Jan 12, 7:30AM CST
Equus Total Return, Inc. (NYSE: EQS) ("Equus" or the "Fund" announced that it has sold its interest in Spectrum Management, L.L.C. ("Spectrum" in exchange for $3.0 million in cash and a 1-year secured subordinated promissory note in the principal amount of $914,509. The note bears interest at 14% per annum and matures one year from the date of issuance.
EQS: 1.78 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

YouTube Shuts Down Tenet Media Channel Amid Legal Issues

Updated Category News Views 305

YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...

Continue Reading
Ardelyx Faces Class Action Lawsuit Amidst Investment Losses

Updated Category News Views 112

Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...

Continue Reading
Derek Bryson Park: Innovator Transforming Finance Worldwide

Updated Category News Views 205

Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...

Continue Reading
Understanding Currency Impacts in Global Trade Dynamics

Updated Category News Views 291

Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...

Continue Reading
Pennant Group Expands Its Operations with Recent Acquisition

Updated Category News Views 283

Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...

Continue Reading